Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 20.71 M40.08 M45.55 M37.68 M 144.02 M Research & development ———— — Operating income 86.64 M70.04 M70.55 M80.19 M 307.41 M Non-Operating Income, Total -24.73 M-24.52 M-26.44 M-29.13 M -104.83 M Interest expense, net of interest capitalized 25.82 M26.47 M28.6 M30.58 M 111.47 M Non-Operating Income, excl. Interest Expenses -24.73 M-24.52 M-26.44 M-29.13 M -104.83 M Unusual income/expense ———— — Pretax income 61.91 M45.51 M44.11 M51.06 M 202.59 M Equity in earnings ———— — Taxes 14.26 M7.15 M6.39 M13.42 M 41.21 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 47.65 M38.36 M37.73 M37.63 M 161.37 M Discontinued operations ———— — Net income 47.65 M38.36 M37.73 M37.63 M 161.37 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 36.56 M34.56 M34.02 M33.8 M 138.94 M Basic earnings per share (Basic EPS) 18.610.59-81.830.61 -62.02 Diluted earnings per share (Diluted EPS) 16.760.59-73.210.61 -55.25 Average basic shares outstanding 2.56 M58.28 M30.02 M55.59 M — Diluted shares outstanding 2.84 M58.28 M30.02 M55.59 M — EBITDA 87.89 M71.39 M71.6 M81.06 M 311.93 M EBIT 86.64 M70.04 M70.55 M80.19 M 307.41 M Cost of revenue 560 K569 K690 K624 K 2.44 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 1.25 M1.35 M1.05 M872 K 4.52 M